Skip to content
Screener

Annexon ANNX Operating Income

Operating Income at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.29B+19.8%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$15.55M-8.0%
Jade Biosciences logo
Jade BiosciencesJBIO
-$43.45M-85.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-$46.53M-40.3%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$57.25M+24.5%
Vor Biopharma logo
Vor BiopharmaVOR
-$35.16M-5.6%

Other financials

Income statement

See full
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$886.39M+244%
Enterprise value$736.61M+381%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Annexon’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211931
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Research and development$35,786$48,179
General and administrative10,2679,226
Total operating expenses46,05357,405
Loss from operations(46,053)(57,405)
Interest and other income, net1,9113,049
Net loss$(44,142)$(54,356)
Net loss per share, basic and diluted$(0.23)$(0.37)
Weighted-average shares used in computing net loss per share, basic and diluted194,200,100148,108,809

Cover / Front Matter

FAQ

What is Annexon's operating income?
Annexon (ANNX) reported operating income of -$46.05M in Q1 2026.
How has Annexon's operating income changed year-over-year?
Annexon's operating income increased by 19.8% year-over-year, from -$57.41M to -$46.05M.
What is the long-term trend for Annexon's operating income?
Over 4 years (2021 to 2025), Annexon's operating income has grown at a 13.4% compound annual growth rate (CAGR), from -$130.71M to -$216.41M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Annexon's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude